✦ LIBER ✦

Long term treatment with infliximab in active crohns disease (CD) patients: Preliminary data

✍ Scribed by M. Costanzo; M. Ciamiello; L. Guidi; A.R. Errani; I. De Vitis; L. Coppola; P. Balistreri; G. Fedeli; G. Gasbanini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The TREAT registry data: Long-term safet

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Infliximab in Crohn's disease: early and

✍ A. Armuzzi; B. De Pascalis; P. Fedeli; F. De Vincentis; A. Gasbarrini 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Factors influencing long-term outcome of

✍ Sachdev, Ritu; Banks, Peter A.; Wolf, Jacqueline L.; Strate, Lisa L.; Friedman, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 233 KB

P430 Long-term outcome of Crohn's diseas

✍ Chen, B.L.; Lv, S.C.; Feng, T.; Li, M.Y.; Rao, P.S.; Zeng, Z.R.; Hu, P.J.; Chen, 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 51 KB

Mucosal distribution of infliximab in pa

✍ Geboes, Karel; Dalle, Ignace; Baert, Filip; D'Haens, Geert; Comillie, Freddy; Ru 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 202 KB

P421 Long term results of infliximab tre

✍ Heitmann, R.; Goll, R.; Florholmen, J.R. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 51 KB